Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

TELIX PHARMACEUTICALS US

Filed by LIBERTY PARTNERS GROUP, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-03 06:26:12 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$40,000.00
Expenses
Not reported
Filing UUID
1e579f93-d695-4cbb-9ee6-de56736d1d0f
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases, Prescription Drug User Fee Amendments

MMM · Medicare/Medicaid

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases, Prescription Drug User Fee Amendments

MED · Medical/Disease Research/Clinical Labs

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases, Prescription Drug User Fee Amendments

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.